Christakis Sergides is the Innovation Director of Medochemie Ltd, a leading generic pharmaceutical manufacturing company in Cyprus. For the last 23 years he has been working in different posts at Medochemie Ltd, including Member of the company’s New Product Development team and Head and Coordinator of the Analytical and Research Laboratories and was also involved in the preparation of Research and Innovation Proposals. He also received on behalf of Medochemie LTD the Cyprus Innovation award 2012 for the manufacturing sector.
He is a Reviewer of Research Scientific Journals of Spandidos Publications and a Qualified Person, registered with Pharmaceutical Authorities of Cyprus.. He has several publications in Journals and has registered patents including the following for 2018: “Amorphous Ivabradine Tosylate: A novel acid addition salt of Ivabradine for Pharmaceutical Use and Preparation Thereof”, WO 2018/115181 and “New Compositions and Uses of Oregano extract”, PCT/EP2018/075037.
Dr Christakis Sergides graduated from Aristotelion University in Greece followed by his postgraduate studies in the U.S.A. He received a Doctorate of Philosophy in Chemistry and was a Postdoctoral Fellow at the University of Denver. , whereas his scientific studies won the American Chemical Society Research Award.
National Board for Research and Innovation
DG EPCD – Directorate General for European Programmes, Coordination and Development
Address: 29, Vyronos Avenue, 1096 Nicosia, Cyprus
Tel.: + 357 22602806
Send us an email